UA87835C2 - 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use in the form of a dpp inhibitor - Google Patents

8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use in the form of a dpp inhibitor

Info

Publication number
UA87835C2
UA87835C2 UAA200609881A UAA200609881A UA87835C2 UA 87835 C2 UA87835 C2 UA 87835C2 UA A200609881 A UAA200609881 A UA A200609881A UA A200609881 A UAA200609881 A UA A200609881A UA 87835 C2 UA87835 C2 UA 87835C2
Authority
UA
Ukraine
Prior art keywords
xanthines
piperidin
amino
production
dpp
Prior art date
Application number
UAA200609881A
Other languages
English (en)
Inventor
Франк Химмельсбах
Эльке Лангкопф
Маттиас Экхардт
Мохаммед Тадайон
Лео Томас
Original Assignee
Бёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бёрингер Ингельхайм Интернациональ Гмбх filed Critical Бёрингер Ингельхайм Интернациональ Гмбх
Publication of UA87835C2 publication Critical patent/UA87835C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA200609881A 2004-02-18 2005-02-12 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use in the form of a dpp inhibitor UA87835C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004008112A DE102004008112A1 (de) 2004-02-18 2004-02-18 8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
UA87835C2 true UA87835C2 (en) 2009-08-25

Family

ID=34813493

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200609881A UA87835C2 (en) 2004-02-18 2005-02-12 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use in the form of a dpp inhibitor

Country Status (5)

Country Link
CN (1) CN1980930B (ru)
AR (1) AR115411A2 (ru)
DE (1) DE102004008112A1 (ru)
UA (1) UA87835C2 (ru)
ZA (1) ZA200604281B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20090938A1 (es) * 2007-08-16 2009-08-08 Boehringer Ingelheim Int Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo
DE102008010661A1 (de) * 2008-02-22 2009-09-03 Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG Verfahren zur Herstellung von Pyridin-2-Boronsäure und Derivaten davon
CN102311448B (zh) * 2010-07-07 2014-02-19 中国科学院广州生物医药与健康研究院 噻吩并嘧啶酮类dpp-iv抑制剂
WO2013010964A1 (en) * 2011-07-15 2013-01-24 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
CN103450201B (zh) * 2012-05-30 2017-04-12 博瑞生物医药（苏州）股份有限公司 手性8‑（3‑氨基哌啶‑1‑基）‑黄嘌呤的制备方法
CN103709163B (zh) * 2012-09-29 2016-12-21 齐鲁制药有限公司 黄嘌呤衍生物、其制备方法及用途
CN103319483B (zh) * 2012-10-19 2016-08-03 药源药物化学（上海）有限公司 一种利拉列汀重要中间体的制备方法
CN103936740B (zh) * 2013-01-23 2016-06-29 成都苑东生物制药股份有限公司 黄嘌呤衍生物
CN106188058B (zh) * 2015-05-29 2020-11-06 江苏天士力帝益药业有限公司 黄嘌呤衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1953162B9 (de) * 2001-02-24 2012-10-31 Boehringer Ingelheim Pharma GmbH & Co. KG Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
CN1980930A (zh) 2007-06-13
ZA200604281B (en) 2007-10-31
CN1980930B (zh) 2012-11-21
AR115411A2 (es) 2021-01-13
DE102004008112A1 (de) 2005-09-01

Similar Documents

Publication Publication Date Title
RS20050137A (en) 8-(3-amino-piperidin-1-yl)-xanthines, the production thereof and the use of the same as medicaments
MY144322A (en) 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
UA87835C2 (en) 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use in the form of a dpp inhibitor
AU2003264060A8 (en) Phenacyl xanthine derivatives as dpp-iv inhibitor
EE05735B1 (et) Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
WO2004046148A8 (de) Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel
UA97468C2 (ru) Комбинация и фармацевтическая композиция, которая содержит 8-[3-аминопиперидин-1-ил]ксантины, способ ее получения и их применение в качестве лекарственного средства
TW200504067A (en) New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
RS20050939A (en) Pyrido/2,1-a/isoquinoline derivatives as dpp-iv inhibitors
WO2003106456A3 (en) NEW COMPOUNDS
UY28069A1 (es) Nuevos derivados de xantina, su preparación y su uso como medicamento
AU2003258621A1 (en) Novel purine derivatives, production and use thereof as medicaments
WO2003074500A3 (en) N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
UA94080C2 (ru) Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
MX2007006837A (es) Difluoronucleosidos y proceso de preparacion de los mismos.
MXPA06000507A (es) Pirazolinas como antagonistas de par-1 para el tratamiento de enfermedades cardiovasculares.
TH74687A (th) 8-[3-อะมิโน-พิเพอริดิน-1-อิล]-แซนธีน, การเตรียมของมันและการใช้ของมันเป็นองค์ประกอบเชิงเภสัชวิทยา